Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty.

Published byFrancis Buck Sanders Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty."— Presentation transcript:

1 Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty. Females had their peak serum B-ALP levels during puberty about 2 yr earlier than males. Values are group mean ± sd. Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy1 J Clin Endocrinol Metab. 1997;82(7): doi: /jcem J Clin Endocrinol Metab | Copyright © 1997 by The Endocrine Society

2 Figure 2. Serum B-ALP levels in normal prepubertal and pubertal children vs. pubertal stage of maturation. A, Serum B-ALP levels in normal prepubertal and pubertal children vs. testicular volume (in 62 males; <4 mL, prepuberty;> 12 mL, adult stage). Serum B-ALP levels vs. stage of breast development (in 39 females) (A) and stage of pubic hair development (in 62 males and 39 females) (C) according to Tanner. Highest serum B-ALP level was observed in midpuberty (stage 3). Values are group mean ± sd, and significance was determined by comparison with prepubertal values: *, P < 0.05. Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy1 J Clin Endocrinol Metab. 1997;82(7): doi: /jcem J Clin Endocrinol Metab | Copyright © 1997 by The Endocrine Society

3 Figure 3. Correlations of serum levels of B-ALP and PICP and osteocalcin in normal male (•) and female (○) children. A significant positive correlation was found between serum levels of B-ALP and PICP (r = 0.447, P < ) and osteocalcin (r = 0.433, P < ). Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy1 J Clin Endocrinol Metab. 1997;82(7): doi: /jcem J Clin Endocrinol Metab | Copyright © 1997 by The Endocrine Society

4 Figure 4. Serum B-ALP response to GH administration
Figure 4. Serum B-ALP response to GH administration. Procedures are described in Subjects and Methods. Serum levels of B-ALP increased significantly during GH administration. Values are group mean ± sd, and significance was determined by comparison with pretreatment values: *, P < Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy1 J Clin Endocrinol Metab. 1997;82(7): doi: /jcem J Clin Endocrinol Metab | Copyright © 1997 by The Endocrine Society

5 Figure 5. Relationship between percent increase in serum B-ALP levels after 3 months of GH treatment and improvement in height sd scores or height velocity sd scores after 1 yr of GH treatment. Percent increases in serum B-ALP levels after 3 months of GH treatment were significantly correlated with increases of height sd score (Δ height sd score; r = 0.531, P < 0.05) or height velocity sd score (Δ height velocity sd score; r = 0.608, P < 0.01) after 1 yr of GH treatment. Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy1 J Clin Endocrinol Metab. 1997;82(7): doi: /jcem J Clin Endocrinol Metab | Copyright © 1997 by The Endocrine Society

6 Figure 6. Relationship between improvement in B-ALP sd score and that in BMD sd score after 1 yr of GH treatment. Procedure is described in Subjects and Methods. Increases in serum B-ALP sd score (Δ B-ALP sd score) were significantly correlated with those in BMD sd score (Δ BMD sd score) after 1 yr of GH treatment (r = 0.663, P < 0.005). Serum Bone Alkaline Phosphatase Isoenzyme Levels in Normal Children and Children with Growth Hormone (GH) Deficiency: A Potential Marker for Bone Formation and Response to GH Therapy1 J Clin Endocrinol Metab. 1997;82(7): doi: /jcem J Clin Endocrinol Metab | Copyright © 1997 by The Endocrine Society

Download ppt "Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty."

Similar presentations

Puberty Female Maturational Changes Male Maturational Changes

Puberty Female Maturational Changes Male Maturational Changes
Approach to the child with short stature

Approach to the child with short stature
Effect of transdermal vs.oral estrogen therapy on achieving near final adult height and near peak bone mass in growth hormone treated adolescents with.

Effect of transdermal vs.oral estrogen therapy on achieving near final adult height and near peak bone mass in growth hormone treated adolescents with.
Aromatase inhibitors in pediatrics short stature and delayed puberty.

Aromatase inhibitors in pediatrics short stature and delayed puberty.
Endocrine Complication in Thalassaemia Major: Growth & Puberty Dr Wong Lap Ming Department of Paediatrics & Adolescent Medicine Tuen Mun Hospital 15-7-2004.

Endocrine Complication in Thalassaemia Major: Growth & Puberty Dr Wong Lap Ming Department of Paediatrics & Adolescent Medicine Tuen Mun Hospital
Normal puberty Dr Neda Mostoufizadeh Pediatric Endocrinologist.

Normal puberty Dr Neda Mostoufizadeh Pediatric Endocrinologist.
Treatment of Precocious puberty

Treatment of Precocious puberty
Growth Hormone Treatment in Children with Malignant Cranial Tumours in KIGS Michael B Ranke and David A Price KIGS 10 Year Book, 1999.

Growth Hormone Treatment in Children with Malignant Cranial Tumours in KIGS Michael B Ranke and David A Price KIGS 10 Year Book, 1999.
The Nature of Adolescence

The Nature of Adolescence
Chapter 15 Adolescent Growth, Puberty, and Reproductive Maturity

Chapter 15 Adolescent Growth, Puberty, and Reproductive Maturity
Defining Insulin-Like Growth Factor-I Deficiency

Defining Insulin-Like Growth Factor-I Deficiency
Puberty and Its Pathophysiology

Puberty and Its Pathophysiology
GROWTH AND PUBERTY Anna Kosmowska.

GROWTH AND PUBERTY Anna Kosmowska.
Short Stature in Noonan Syndrome: Demography and Response to Growth Hormone Treatment in KIGS Barto J Otten KIGS 10 Year Book, 1999.

Short Stature in Noonan Syndrome: Demography and Response to Growth Hormone Treatment in KIGS Barto J Otten KIGS 10 Year Book, 1999.
Development of the KIGS Model for Predicting Growth Response to Growth Hormone Replacement Therapy in Children with Idiopathic Growth Hormone Deficiency.

Development of the KIGS Model for Predicting Growth Response to Growth Hormone Replacement Therapy in Children with Idiopathic Growth Hormone Deficiency.
Precocious puberty A case

Precocious puberty A case
Final Height Following Growth Hormone Treatment of Idiopathic Growth Hormone Deficiency in KIGS Wayne S Cutfield, Anders Lindberg, Pierre Chatelain, David.

Final Height Following Growth Hormone Treatment of Idiopathic Growth Hormone Deficiency in KIGS Wayne S Cutfield, Anders Lindberg, Pierre Chatelain, David.
Figure 1. Mass of rapid insulin secretory bursts and ApEn values in young and old subjects. Increased Disorderliness of Basal Insulin Release, Attenuated.

Figure 1. Mass of rapid insulin secretory bursts and ApEn values in young and old subjects. Increased Disorderliness of Basal Insulin Release, Attenuated.
Figure 2. ROC curves for fasting values (A) and OGTT values (B) for detecting insulin resistance in PCOS women. Sensitivity is plotted against 1 − specificity.

Figure 2. ROC curves for fasting values (A) and OGTT values (B) for detecting insulin resistance in PCOS women. Sensitivity is plotted against 1 − specificity.
Girl, 13-4/12 years old, with constitutional delay in growth and puberty. History revealed a normal growth rate but short stature at all ages. Physical.

Girl, 13-4/12 years old, with constitutional delay in growth and puberty. History revealed a normal growth rate but short stature at all ages. Physical.

Similar presentations

Ads by Google